Literature DB >> 11407153

Advanced biliary atresia: is portoenterostomy justified in all infants?

D K Gupta1, S Dave.   

Abstract

During 1989-98, of the 127 patients with biliary atresia, 23 were seen with advanced biliary atresia (ABA) presenting with (i) at more than 120 days of age (ii) established cirrhosis and (iii) features of portal hypertension. Sixteen of these underwent exploratory laparotomy, dissection at the porta hepatis and hepatico-portoenterostomy (HPE) (group I). The remaining 7 infants underwent portal dissection and sump drainage only (instead of HPE). The drainage if any was evaluated for any change in colour, volume and concentration in the post-operative period (group II). Age and presentation were the same in both the groups. In group-II, HPE was considered only if the bile flow was noted after portal dissection. Bile flow was seen in 3/16 in group I and 0/7 in group II. The fall in serum bilirubin during the first seven post operative days was noted in 2/16 in group I and 0/7 in group II. No drain output was recorded in any of the group II infants. The incidence of complications and the duration of hospital stay was significantly higher in group I patients. The sump drainage as an alternative procedure to HPE not only served the purpose of evaluating the patients with ABA for the possible bile flow in the post operative period but also avoided the need for a major operative procedure like HPE.

Entities:  

Mesh:

Year:  2001        PMID: 11407153     DOI: 10.1007/bf02723013

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  9 in total

1.  Biliary atresia: should all patients undergo a portoenterostomy?

Authors:  K S Azarow; M J Phillips; A D Sandler; I Hagerstrand; R A Superina
Journal:  J Pediatr Surg       Date:  1997-02       Impact factor: 2.545

2.  Indication of Kasai's operation for biliary atresia: for early decision of liver transplantation.

Authors:  T Chiba
Journal:  Nihon Geka Hokan       Date:  1988-07-01

3.  Long-term follow-up after surgery for patients with biliary atresia.

Authors:  R Ohi; M Nio; T Chiba; N Endo; M Goto; M Ibrahim
Journal:  J Pediatr Surg       Date:  1990-04       Impact factor: 2.545

4.  Long-term results with the Kasai operation for biliary atresia.

Authors:  F M Karrer; M R Price; D D Bensard; R J Sokol; M R Narkewicz; D J Smith; J R Lilly
Journal:  Arch Surg       Date:  1996-05

5.  Long-term outcome after surgery for biliary atresia. Study of 40 patients surviving for more than 10 years.

Authors:  J Laurent; F Gauthier; O Bernard; M Hadchouel; M Odièvre; J Valayer; D Alagille
Journal:  Gastroenterology       Date:  1990-12       Impact factor: 22.682

6.  Current status of 21 patients who have survived more than 20 years since undergoing surgery for biliary atresia.

Authors:  M Nio; R Ohi; Y Hayashi; N Endo; M Ibrahim; D Iwami
Journal:  J Pediatr Surg       Date:  1996-03       Impact factor: 2.545

7.  Conventional treatment of biliary atresia: long-term results.

Authors:  J Valayer
Journal:  J Pediatr Surg       Date:  1996-11       Impact factor: 2.545

8.  Current concept of the treatment of biliary atresia.

Authors:  T Miyano; T Fujimoto; T Ohya; H Shimomura
Journal:  World J Surg       Date:  1993 May-Jun       Impact factor: 3.352

9.  Ongoing cirrhosis after successful porticoenterostomy in infants with biliary atresia.

Authors:  R P Altman; R Chandra; J R Lilly
Journal:  J Pediatr Surg       Date:  1975-10       Impact factor: 2.545

  9 in total
  2 in total

Review 1.  Surgical modifications, additions, and alternatives to Kasai hepato-portoenterostomy to improve the outcome in biliary atresia.

Authors:  Shilpa Sharma; Devendra K Gupta
Journal:  Pediatr Surg Int       Date:  2017-10-04       Impact factor: 1.827

2.  Bone marrow mononuclear stem cell infusion improves biochemical parameters and scintigraphy in infants with biliary atresia.

Authors:  Shilpa Sharma; Lalit Kumar; Sujata Mohanty; Rakesh Kumar; S Datta Gupta; Devendra K Gupta
Journal:  Pediatr Surg Int       Date:  2011-01       Impact factor: 1.827

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.